Ten63 Therapeutics

AI-enabled drug design

This company develops generative machine learning platforms to design and optimise small-molecule drug candidates for pharmaceutical and biotechnology partners.

UbiquiTx

This company develops a programmable protein modulation platform using artificial intelligence to create targeted therapies for pharmaceutical businesses and patients with complex diseases.

Generate Biomedicine

This company develops protein-based therapeutics using a generative artificial intelligence platform for pharmaceutical partners and biotechnology firms.

Auron Therapeutics

This company develops small-molecule drugs using an AI-powered platform to treat patients with cancer and inflammatory diseases.

Ternary Therapeutics

This company develops an artificial intelligence platform to design molecular glue therapeutics for healthcare providers and pharmaceutical partners to treat complex diseases.

Molecular Glue Labs

This company develops artificial intelligence software and infrastructure to design small-molecule drugs that reprogram protein networks to treat previously untreatable diseases.

CHARM Therapeutics

This company develops small-molecule drugs for cancer patients using a deep-learning platform that models protein-ligand interactions to identify novel therapeutic targets.

Serna Bio

This company develops an AI-native platform to discover small molecule drugs targeting RNA for pharmaceutical partners treating respiratory and other complex diseases.